{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:08:40Z","timestamp":1789243720710,"version":"build-2803163510"},"reference-count":279,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970804"],"award-info":[{"award-number":["81970804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["CX20240311"],"award-info":[{"award-number":["CX20240311"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["2024ZZTS0963"],"award-info":[{"award-number":["2024ZZTS0963"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.intimp.2026.116781","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:25:36Z","timestamp":1778318736000},"page":"116781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Microglia crosstalk with T cells in neurodegenerative diseases: pathogenesis and treatment targets"],"prefix":"10.1016","volume":"182","author":[{"given":"Gong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116781_bb0005","doi-asserted-by":"crossref","unstructured":"W. Elyaman, Adaptive Immunity and Parkinson\u2019s Disease, Cold Spring Harb. Perspect. Med. (2025). Advanced Online Article. DOI: 10.1101\/cshperspect.a041639.","DOI":"10.1101\/cshperspect.a041639"},{"issue":"10","key":"10.1016\/j.intimp.2026.116781_bb0010","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb0015","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.immuni.2022.10.016","article-title":"Emerging roles of innate and adaptive immunity in Alzheimer's disease","volume":"55","author":"Chen","year":"2022","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb0020","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41582-019-0253-6","article-title":"When encephalitogenic T cells collaborate with microglia in multiple sclerosis","volume":"15","author":"Dong","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"7953","key":"10.1016\/j.intimp.2026.116781_bb0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","article-title":"Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy","volume":"615","author":"Chen","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0030","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41593-025-01955-w","article-title":"Microglia activation orchestrates CXCL10-mediated CD8(+) T cell recruitment to promote aging-related white matter degeneration","volume":"28","author":"Groh","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.intimp.2026.116781_bb0035","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/s41593-022-01183-6","article-title":"CD8(+) T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging","volume":"25","author":"Kaya","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.intimp.2026.116781_bb0040","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41593-024-01682-8","article-title":"T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis","volume":"27","author":"Kedia","year":"2024","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116781_bb0050","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41577-023-00907-4","article-title":"Microglia regulation of central nervous system myelin health and regeneration","volume":"24","author":"Kent","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-022-02605-9","article-title":"The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases","volume":"19","author":"DeMaio","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41582-024-01046-7","article-title":"Immune mechanisms and shared immune targets in neurodegenerative diseases","volume":"21","author":"Weiner","year":"2025","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb0070","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","article-title":"Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting","volume":"186","author":"Charabati","year":"2023","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.intimp.2026.116781_bb0075","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: A field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1017\/S1740925X12000038","article-title":"The role of microglia at synapses in the healthy CNS: novel insights from recent imaging studies","volume":"7","author":"Tremblay","year":"2011","journal-title":"Neuron Glia Biol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116781_bb0085","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb0090","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb0095","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.celrep.2017.09.039","article-title":"Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution","volume":"21","author":"Mathys","year":"2017","journal-title":"Cell Rep."},{"issue":"13","key":"10.1016\/j.intimp.2026.116781_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107843","article-title":"Alzheimer's Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation","volume":"31","author":"Srinivasan","year":"2020","journal-title":"Cell Rep."},{"issue":"20","key":"10.1016\/j.intimp.2026.116781_bb0105","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1016\/j.cell.2023.08.005","article-title":"Early Alzheimer's disease pathology in human cortex involves transient cell states","volume":"186","author":"Gazestani","year":"2023","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0110","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/brain\/awab446","article-title":"Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state","volume":"145","author":"Smajic","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-024-01590-1","article-title":"Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson's disease","volume":"22","author":"Quan","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0120","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1007\/s10753-025-02306-4","article-title":"Integrated Analysis of Single-Cell and Transcriptome Data Reveals the Role and Regulatory Mechanisms of Neuroinflammation in Parkinson's Disease","volume":"48","author":"Geng","year":"2025","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0125","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1038\/s41467-023-39060-w","article-title":"Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease","volume":"14","author":"Schonhoff","year":"2023","journal-title":"Nat. Commun."},{"issue":"7744","key":"10.1016\/j.intimp.2026.116781_bb0130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb0135","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1016\/j.immuni.2025.10.003","article-title":"Single-cell spatial transcriptomic profiling defines a pathogenic inflammatory niche in chronic active multiple sclerosis lesions","volume":"58","author":"Feng","year":"2025","journal-title":"Immunity"},{"issue":"7878","key":"10.1016\/j.intimp.2026.116781_bb0140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0145","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.immuni.2024.05.005","article-title":"An inducible genetic tool to track and manipulate specific microglial states reveals their plasticity and roles in remyelination","volume":"57","author":"Barclay","year":"2024","journal-title":"Immunity"},{"issue":"10043","key":"10.1016\/j.intimp.2026.116781_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb0155","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202717","article-title":"Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice?","volume":"218","author":"Chen","year":"2021","journal-title":"J. Exp. Med."},{"issue":"Pt 4","key":"10.1016\/j.intimp.2026.116781_bb0160","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/brain\/aww016","article-title":"Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-beta pathology","volume":"139","author":"Spangenberg","year":"2016","journal-title":"Brain"},{"issue":"6286","key":"10.1016\/j.intimp.2026.116781_bb0165","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"issue":"Pt 12","key":"10.1016\/j.intimp.2026.116781_bb0170","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1093\/brain\/awt273","article-title":"Cell number changes in Alzheimer\u2019s disease relate to dementia, not to plaques and tangles","volume":"136","author":"Andrade-Moraes","year":"2013","journal-title":"Brain"},{"issue":"13","key":"10.1016\/j.intimp.2026.116781_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110148","article-title":"The microglial P2Y(6) receptor mediates neuronal loss and memory deficits in neurodegeneration","volume":"37","author":"Puigdellivol","year":"2021","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nn.2511","article-title":"Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer\u2019s disease","volume":"13","author":"Fuhrmann","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb0185","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","article-title":"Microglia use TAM receptors to detect and engulf amyloid beta plaques","volume":"22","author":"Huang","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.116781_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104956","article-title":"Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies","volume":"142","author":"Casali","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.intimp.2026.116781_bb0195","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn.2432","article-title":"Formation and maintenance of Alzheimer\u2019s disease beta-amyloid plaques in the absence of microglia","volume":"12","author":"Grathwohl","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0200","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","article-title":"Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model","volume":"10","author":"Spangenberg","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41582-025-01162-y","article-title":"Microglial phagocytosis in Alzheimer disease","volume":"22","author":"Brown","year":"2026","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116781_bb0210","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson's disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0215","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-017-0195-7","article-title":"Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal alpha-synucleinopathy","volume":"12","author":"Venezia","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0220","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/00207454.2016.1264072","article-title":"Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases","volume":"127","author":"Han","year":"2017","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.intimp.2026.116781_bb0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.parkreldis.2021.09.007","article-title":"Toll-like receptor 4 deficiency facilitates alpha-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson's disease","volume":"91","author":"Venezia","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6512","key":"10.1016\/j.intimp.2026.116781_bb0230","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.abb8587","article-title":"Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases","volume":"370","author":"Bartels","year":"2020","journal-title":"Science"},{"issue":"376","key":"10.1016\/j.intimp.2026.116781_bb0235","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","article-title":"Activation of MyD88-dependent TLR1\/2 signaling by misfolded alpha-synuclein, a protein linked to neurodegenerative disorders","volume":"8","author":"Daniele","year":"2015","journal-title":"Sci. Signal."},{"issue":"10291","key":"10.1016\/j.intimp.2026.116781_bb0240","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.17","article-title":"IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease","volume":"2","author":"Barcia","year":"2011","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0250","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12974-024-03234-0","article-title":"Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson's disease","volume":"21","author":"Yao","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0255","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","article-title":"Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis","volume":"135","author":"Luchetti","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0260","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1523\/JNEUROSCI.2615-05.2006","article-title":"Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation","volume":"26","author":"Kotter","year":"2006","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb0265","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41583-023-00709-6","article-title":"Roles and regulation of microglia activity in multiple sclerosis: insights from animal models","volume":"24","author":"Distefano-Gagne","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40478-016-0343-2","article-title":"LRP1 expression in microglia is protective during CNS autoimmunity","volume":"4","author":"Chuang","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0275","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/jnc.15327","article-title":"Microglial phagocytosis of neurons in neurodegeneration, and its regulation","volume":"158","author":"Butler","year":"2021","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","article-title":"Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis","volume":"24","author":"Berghoff","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0285","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41467-021-22532-2","article-title":"Microglial neuropilin-1 promotes oligodendrocyte expansion during development and remyelination by trans-activating platelet-derived growth factor receptor","volume":"12","author":"Sherafat","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00401-025-02893-4","article-title":"Thalamic atrophy in multiple sclerosis is associated with tract disconnection and altered microglia","volume":"149","author":"Rodriguez-Mogeda","year":"2025","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb0295","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jmb.2019.02.004","article-title":"Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia","volume":"431","author":"Haukedal","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.intimp.2026.116781_bb0300","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0305","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00401-018-1875-2","article-title":"Nucleo-cytoplasmic transport of TDP-43 studied in real time: impaired microglia function leads to axonal spreading of TDP-43 in degenerating motor neurons","volume":"136","author":"Svahn","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0310","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb0315","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"issue":"7434","key":"10.1016\/j.intimp.2026.116781_bb0320","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.intimp.2026.116781_bb0325","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by beta-amyloid in Alzheimer disease","volume":"89","author":"Rogers","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116781_bb0330","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fimmu.2020.00724","article-title":"TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116781_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in Glaucoma: From the back to the front of the eye, and beyond","volume":"83","author":"Baudouin","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0340","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12974-021-02366-x","article-title":"Interplay between Muller cells and microglia aggravates retinal inflammatory response in experimental glaucoma","volume":"18","author":"Hu","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb0345","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1167\/iovs.10-5284","article-title":"Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury","volume":"51","author":"Ebneter","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.intimp.2026.116781_bb0350","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-2094-9-92","article-title":"IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma","volume":"9","author":"Gallego","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042066","article-title":"Retinal Molecular Changes Are Associated with Neuroinflammation and Loss of RGCs in an Experimental Model of Glaucoma","volume":"22","author":"Fernandez-Albarral","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116781_bb0360","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12974-016-0509-7","article-title":"Bilateral neuroinflammatory processes in visual pathways induced by unilateral ocular hypertension in the rat","volume":"13","author":"Sapienza","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116781_bb0365","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2014.07.001","article-title":"Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases","volume":"43","author":"Cuenca","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.intimp.2026.116781_bb0370","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fnmol.2019.00314","article-title":"Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis","volume":"12","author":"Zheng","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.116781_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119567","article-title":"Asiatic acid attenuates diabetic retinopathy through TLR4\/MyD88\/NF-kappaB p65 mediated modulation of microglia polarization","volume":"277","author":"Fang","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0380","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/s41467-018-05681-9","article-title":"Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb0385","first-page":"2277","article-title":"Autoantibodies to small heat shock proteins in glaucoma","volume":"39","author":"Tezel","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0390","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archopht.118.4.511","article-title":"Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes","volume":"118","author":"Tezel","year":"2000","journal-title":"Arch. Ophthalmol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116781_bb0395","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb0400","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41423-019-0220-6","article-title":"Helper T cell differentiation","volume":"16","author":"Saravia","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"1-2","key":"10.1016\/j.intimp.2026.116781_bb0405","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-5728(01)00496-9","article-title":"Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases","volume":"124","author":"Togo","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2026.116781_bb0410","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3389\/fimmu.2018.01213","article-title":"Imbalance of Circulating T(h)17 and Regulatory T Cells in Alzheimer's Disease: A Case Control Study","volume":"9","author":"Oberstein","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0415","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2009-1015","article-title":"Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease","volume":"17","author":"Larbi","year":"2009","journal-title":"J. Alzheimer's Dis"},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb0420","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/acn3.51643","article-title":"Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease","volume":"9","author":"Zhang","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0425","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bbi.2010.01.003","article-title":"Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells","volume":"24","author":"McQuillan","year":"2010","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0430","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12974-021-02308-7","article-title":"CD4+ effector T cells accelerate Alzheimer's disease in mice","volume":"18","author":"Machhi","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116781_bb0435","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.isci.2019.05.039","article-title":"CD4 T Cells Induce A Subset of MHCII-Expressing Microglia that Attenuates Alzheimer Pathology","volume":"16","author":"Mittal","year":"2019","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0440","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple Sclerosis: Mechanisms and Immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152023","article-title":"PAF-R on activated T cells: Role in the IL-23\/Th17 pathway and relevance to multiple sclerosis","volume":"226","author":"Midgley","year":"2021","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0450","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","article-title":"Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances","volume":"20","author":"Bar-Or","year":"2021","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0455","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/intimm\/dxu096","article-title":"Therapeutic uses of anti-alpha4-integrin (anti-VLA-4) antibodies in multiple sclerosis","volume":"27","author":"Schwab","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.intimp.2026.116781_bb0460","article-title":"Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0465","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1167\/iovs.18-26129","article-title":"T-Lymphocyte Subset Distribution and Activity in Patients With Glaucoma","volume":"60","author":"Yang","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0470","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12974-024-03035-5","article-title":"Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner","volume":"21","author":"He","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100310","article-title":"Association between HSP-Specific T-Cell Counts and Retinal Nerve Fiber Layer Thickness in Patients with Primary Open-Angle Glaucoma","volume":"3","author":"Saini","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.intimp.2026.116781_bb0480","doi-asserted-by":"crossref","first-page":"1233870","DOI":"10.3389\/fimmu.2023.1233870","article-title":"The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders","volume":"14","author":"Terrabuio","year":"2023","journal-title":"Front. Immunol."},{"issue":"7790","key":"10.1016\/j.intimp.2026.116781_bb0485","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","article-title":"Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease","volume":"577","author":"Gate","year":"2020","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.intimp.2026.116781_bb0490","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1016\/j.cell.2022.11.019","article-title":"Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment","volume":"185","author":"Piehl","year":"2022","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb0495","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","article-title":"Infiltrating CD8(+) T cells exacerbate Alzheimer's disease pathology in a 3D human neuroimmune axis model","volume":"26","author":"Jorfi","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"29","key":"10.1016\/j.intimp.2026.116781_bb0500","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2401420121","article-title":"Antigen-specific age-related memory CD8 T cells induce and track Alzheimer's-like neurodegeneration","volume":"121","author":"Panwar","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.116781_bb0505","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbi.2024.08.045","article-title":"CD8(+) T cells exacerbate AD-like symptoms in mouse model of amyloidosis","volume":"122","author":"Wang","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0510","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-024-00706-y","article-title":"Unraveling the dual nature of brain CD8(+) T cells in Alzheimer's disease","volume":"19","author":"Hu","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.intimp.2026.116781_bb0515","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41590-023-01604-z","article-title":"CXCR6 orchestrates brain CD8(+) T cell residency and limits mouse Alzheimer's disease pathology","volume":"24","author":"Su","year":"2023","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0520","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/acn3.199","article-title":"Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis","volume":"2","author":"Salou","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0525","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.192.3.393","article-title":"Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction","volume":"192","author":"Babbe","year":"2000","journal-title":"J. Exp. Med."},{"issue":"Pt 12","key":"10.1016\/j.intimp.2026.116781_bb0530","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1093\/brain\/awr268","article-title":"Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on alpha4 integrin","volume":"134","author":"Ifergan","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0535","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awaa117","article-title":"Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions","volume":"143","author":"Fransen","year":"2020","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0540","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029025","article-title":"Effector T Cells in Multiple Sclerosis","volume":"8","author":"Kaskow","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"21","key":"10.1016\/j.intimp.2026.116781_bb0545","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162788","article-title":"CD8+ T cells recognizing a neuron-restricted antigen injure axons in a model of multiple sclerosis","volume":"133","author":"Clarkson","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb0550","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jaut.2010.12.003","article-title":"Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis","volume":"36","author":"Baughman","year":"2011","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0555","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200016","article-title":"Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8(+) Regulatory T Cells","volume":"9","author":"Benallegue","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0560","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0404.2011.01528.x","article-title":"Alterations of T cell subsets in ALS: a systemic immune activation?","volume":"125","author":"Rentzos","year":"2012","journal-title":"Acta Neurol. Scand."},{"issue":"7916","key":"10.1016\/j.intimp.2026.116781_bb0565","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41586-022-04844-5","article-title":"Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4","volume":"606","author":"Campisi","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0570","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1073\/pnas.1815961116","article-title":"Cytotoxic CD8(+) T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons","volume":"116","author":"Coque","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0575","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12974-016-0732-2","article-title":"Immune response in peripheral axons delays disease progression in SOD1(G93A) mice","volume":"13","author":"Nardo","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"18","key":"10.1016\/j.intimp.2026.116781_bb0580","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.7150\/thno.75965","article-title":"Adoptive therapy with amyloid-beta specific regulatory T cells alleviates Alzheimer's disease","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2026.116781_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117721","article-title":"A preclinical and phase I clinical study of ex vivo-expanded amyloid beta-specific human regulatory T cells in Alzheimer's disease","volume":"181","author":"Yang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0590","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40035-023-00387-5","article-title":"A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease","volume":"12","author":"Faridar","year":"2023","journal-title":"Transl Neurodegener"},{"issue":"16","key":"10.1016\/j.intimp.2026.116781_bb0595","doi-asserted-by":"crossref","DOI":"10.3390\/cells12162115","article-title":"Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer's Disease","volume":"12","author":"Saetzler","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0600","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13024-023-00692-7","article-title":"Amyloid-beta specific regulatory T cells attenuate Alzheimer's disease pathobiology in APP\/PS1 mice","volume":"18","author":"Yeapuri","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"5176","key":"10.1016\/j.intimp.2026.116781_bb0605","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7520605","article-title":"Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis","volume":"265","author":"Chen","year":"1994","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0610","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/eji.200839073","article-title":"Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg","volume":"39","author":"Stephens","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"20","key":"10.1016\/j.intimp.2026.116781_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015237","article-title":"Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson's Disease Progression in Mice","volume":"24","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 5","key":"10.1016\/j.intimp.2026.116781_bb0620","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0625","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41590-022-01208-z","article-title":"Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation","volume":"23","author":"Yshii","year":"2022","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0630","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200019","article-title":"Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis","volume":"9","author":"Thonhoff","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0635","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12974-024-03262-w","article-title":"MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis","volume":"21","author":"Frikeche","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb0640","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcyt.2023.11.007","article-title":"Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulation","volume":"26","author":"Graber","year":"2024","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0645","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1084\/jem.182.6.1985","article-title":"Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions","volume":"182","author":"Windhagen","year":"1995","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0650","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1073\/pnas.93.6.2499","article-title":"CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis","volume":"93","author":"Gerritse","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb0655","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","article-title":"Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0660","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4049\/jimmunol.176.3.1402","article-title":"CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation","volume":"176","author":"Ponomarev","year":"2006","journal-title":"J. Immunol."},{"issue":"31","key":"10.1016\/j.intimp.2026.116781_bb0665","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau8380","article-title":"Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation","volume":"4","author":"Mundt","year":"2019","journal-title":"Sci. Immunol."},{"issue":"6425","key":"10.1016\/j.intimp.2026.116781_bb0670","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat7554","article-title":"Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation","volume":"363","author":"Jordao","year":"2019","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb0675","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.immuni.2023.04.013","article-title":"Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis","volume":"56","author":"Kiss","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0680","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12974-025-03449-9","article-title":"Brd4 expression in CD4 T cells and in microglia promotes neuroinflammation in experimental autoimmune encephalomyelitis","volume":"22","author":"Dey","year":"2025","journal-title":"J. Neuroinflammation"},{"issue":"6774","key":"10.1016\/j.intimp.2026.116781_bb0685","doi-asserted-by":"crossref","first-page":"eadq1177","DOI":"10.1126\/science.adq1177","article-title":"Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration","volume":"390","author":"Li","year":"2025","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb0690","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41590-022-01360-6","article-title":"Cognate microglia-T cell interactions shape the functional regulatory T cell pool in experimental autoimmune encephalomyelitis pathology","volume":"23","author":"Haimon","year":"2022","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116781_bb0695","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.4049\/jimmunol.1203331","article-title":"Microglial activation milieu controls regulatory T cell responses","volume":"191","author":"Ebner","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0700","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1038\/s41467-025-60363-7","article-title":"TGFalpha controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation","volume":"16","author":"Losslein","year":"2025","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb0705","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells","volume":"7","author":"Batten","year":"2006","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb0710","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.179.5.3268","article-title":"Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis","volume":"179","author":"Fitzgerald","year":"2007","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb0715","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/ni1540","article-title":"Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells","volume":"8","author":"Fitzgerald","year":"2007","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116781_bb0720","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.4103\/1673-5374.336134","article-title":"Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases","volume":"17","author":"Nortey","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0725","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/glia.22948","article-title":"Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses","volume":"64","author":"Senecal","year":"2016","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0730","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbi.2010.01.014","article-title":"Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis","volume":"24","author":"Murphy","year":"2010","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0735","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12974-024-03326-x","article-title":"Microglia and Immune cells interactions in multiple sclerosis cognitive impairment: a postmortem study","volume":"21","author":"Barros","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.intimp.2026.116781_bb0740","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41593-019-0427-y","article-title":"T cells promote microglia-mediated synaptic elimination and cognitive dysfunction during recovery from neuropathogenic flaviviruses","volume":"22","author":"Garber","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb0745","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0750","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.immuni.2015.08.010","article-title":"The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity","volume":"43","author":"Croxford","year":"2015","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb0755","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41590-021-01117-7","article-title":"IFNgamma and GM-CSF control complementary differentiation programs in the monocyte-to-phagocyte transition during neuroinflammation","volume":"23","author":"Amorim","year":"2022","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116781_bb0760","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41591-019-0521-4","article-title":"GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis","volume":"25","author":"Galli","year":"2019","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0765","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1750-3639.2000.tb00268.x","article-title":"Axonal damage induced by invading T cells in organotypic central nervous system tissue in vitro: involvement of microglial cells","volume":"10","author":"Gimsa","year":"2000","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb0770","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00401-014-1317-8","article-title":"Demyelination during multiple sclerosis is associated with combined activation of microglia\/macrophages by IFN-gamma and alpha B-crystallin","volume":"128","author":"Bsibsi","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb0775","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4049\/jimmunol.1401156","article-title":"Direct and indirect effects of immune and central nervous system-resident cells on human oligodendrocyte progenitor cell differentiation","volume":"194","author":"Moore","year":"2015","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb0780","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41593-019-0418-z","article-title":"Central nervous system regeneration is driven by microglia necroptosis and repopulation","volume":"22","author":"Lloyd","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"Pt 5","key":"10.1016\/j.intimp.2026.116781_bb0785","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/aws058","article-title":"Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor gamma","volume":"135","author":"Hucke","year":"2012","journal-title":"Brain"},{"issue":"25","key":"10.1016\/j.intimp.2026.116781_bb0790","doi-asserted-by":"crossref","first-page":"22424","DOI":"10.1074\/jbc.M301789200","article-title":"Role of very-late antigen-4 (VLA-4) in myelin basic protein-primed T cell contact-induced expression of proinflammatory cytokines in microglial cells","volume":"278","author":"Dasgupta","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.intimp.2026.116781_bb0795","doi-asserted-by":"crossref","first-page":"32222","DOI":"10.1074\/jbc.M702899200","article-title":"Myelin basic protein-primed T cells induce neurotrophins in glial cells via alphavbeta3 [corrected] integrin","volume":"282","author":"Roy","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2026.116781_bb0800","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/jir.2014.0019","article-title":"Interactions between microglia and T cells in multiple sclerosis pathobiology","volume":"34","author":"Strachan-Whaley","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0805","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12974-019-1453-0","article-title":"Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease","volume":"16","author":"Dionisio-Santos","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116781_bb0810","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.592359","article-title":"The Complexity of Microglial Interactions With Innate and Adaptive Immune Cells in Alzheimer's Disease","volume":"12","author":"Wyatt-Johnson","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0815","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.immuni.2026.02.004","article-title":"Immunity in Alzheimer's disease: From mechanisms to therapies","volume":"59","author":"Chen","year":"2026","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0820","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12974-018-1304-4","article-title":"Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice","volume":"15","author":"Unger","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb0825","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.4049\/jimmunol.1200947","article-title":"IFN-gamma Production by amyloid beta-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer\u2019s disease","volume":"190","author":"Browne","year":"2013","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb0830","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41593-023-01417-1","volume":"26","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"36","key":"10.1016\/j.intimp.2026.116781_bb0835","doi-asserted-by":"crossref","first-page":"eabh0609","DOI":"10.1126\/sciadv.abh0609","article-title":"Microglia promote autoimmune inflammation via the noncanonical NF-kappaB pathway","volume":"7","author":"Jie","year":"2021","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb0840","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.immuni.2016.10.026","article-title":"GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation","volume":"45","author":"Becher","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116781_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101523","article-title":"Targeting GM-CSF in inflammatory and autoimmune disorders","volume":"54","author":"Achuthan","year":"2021","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116781_bb0850","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1471-4906(02)02260-3","article-title":"GM-CSF in inflammation and autoimmunity","volume":"23","author":"Hamilton","year":"2002","journal-title":"Trends Immunol."},{"issue":"37","key":"10.1016\/j.intimp.2026.116781_bb0855","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309221120","article-title":"Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease","volume":"120","author":"Lopes","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb0860","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb0865","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41590-025-02198-4","article-title":"Granzyme K(+) CD8 T cells slow tauopathy progression by targeting microglia","volume":"26","author":"Mason","year":"2025","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0870","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0875","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00401-020-02187-x","article-title":"Interleukin-1 promotes autoimmune neuroinflammation by suppressing endothelial heme oxygenase-1 at the blood-brain barrier","volume":"140","author":"Hauptmann","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb0880","article-title":"Effects of Natural Polyphenols on Oxidative Stress-Mediated Blood-Brain Barrier Dysfunction","volume":"11","author":"Kim","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb0885","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0890","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb0895","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI11902","article-title":"Bonzo\/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential","volume":"107","author":"Kim","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb0900","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1074\/jbc.M311660200","article-title":"CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation","volume":"279","author":"Chandrasekar","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0905","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12974-023-02723-y","article-title":"The reciprocal interactions between microglia and T cells in Parkinson's disease: a double-edged sword","volume":"20","author":"Xu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116781_bb0910","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0915","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb0920","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson's disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.intimp.2026.116781_bb0925","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","article-title":"T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases","volume":"11","author":"Gonzalez","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"23","key":"10.1016\/j.intimp.2026.116781_bb0930","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb0935","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12974-018-1286-2","article-title":"Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease","volume":"15","author":"Williams","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116781_bb0940","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebrian","year":"2014","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb0945","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.4103\/1673-5374.313057","article-title":"Stress increases MHC-I expression in dopaminergic neurons and induces autoimmune activation in Parkinson's disease","volume":"16","author":"Wang","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb0950","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1182\/blood.V99.9.3427","article-title":"Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide","volume":"99","author":"Bosisio","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116781_bb0955","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fnins.2020.00444","article-title":"Inhibition of TLR4 Induces M2 Microglial Polarization and Provides Neuroprotection via the NLRP3 Inflammasome in Alzheimer's Disease","volume":"14","author":"Cui","year":"2020","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb0960","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.immuni.2023.07.015","article-title":"CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma","volume":"56","author":"Chen","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116781_bb0965","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/srep00809","article-title":"ROCK\/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo","volume":"2","author":"Barcia","year":"2012","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0970","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1471-4159.2009.06189.x","article-title":"Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"110","author":"Marinova-Mutafchieva","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2026.116781_bb0975","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","article-title":"IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease","volume":"81","author":"Liu","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb0980","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"issue":"18","key":"10.1016\/j.intimp.2026.116781_bb0985","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.2174\/092986708785133031","article-title":"Biochemical markers in CSF of ALS patients","volume":"15","author":"Sussmuth","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2026.116781_bb0990","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"issue":"46","key":"10.1016\/j.intimp.2026.116781_bb0995","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1073\/pnas.0804610105","article-title":"T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb1000","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.10805","article-title":"Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue","volume":"55","author":"Henkel","year":"2004","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb1005","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.nbd.2012.07.008","article-title":"Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms","volume":"48","author":"Zhao","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb1010","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.4049\/jimmunol.181.3.2220","article-title":"Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1","volume":"181","author":"Savage","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb1015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","article-title":"Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis","volume":"12","author":"Hooten","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.intimp.2026.116781_bb1020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fnins.2020.00575","article-title":"Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis","volume":"14","author":"Liu","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb1025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-018-0271-7","article-title":"Counteracting roles of MHCI and CD8(+) T cells in the peripheral and central nervous system of ALS SOD1(G93A) mice","volume":"13","author":"Nardo","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb1030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s40478-025-02066-0","article-title":"Glial and immune dysregulation in glaucoma independent of retinal ganglion cell loss: a human post-mortem histopathology study","volume":"13","author":"Salkar","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.intimp.2026.116781_bb1035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuint.2017.04.014","article-title":"Poly(ADP-ribose) polymerase-1 regulates microglia mediated decrease of endothelial tight junction integrity","volume":"108","author":"Mehrabadi","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.intimp.2026.116781_bb1040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-015-0234-y","article-title":"Adoptive transfer of immune cells from glaucomatous mice provokes retinal ganglion cell loss in recipients","volume":"3","author":"Gramlich","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.intimp.2026.116781_bb1045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803485","article-title":"T Cell-Mediated Autoimmunity in Glaucoma Neurodegeneration","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb1050","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1167\/iovs.02-0912","article-title":"Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model","volume":"44","author":"Ishii","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb1055","first-page":"1522","article-title":"Induction of heat shock protein 72 protects retinal ganglion cells in a rat glaucoma model","volume":"42","author":"Park","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"46","key":"10.1016\/j.intimp.2026.116781_bb1060","doi-asserted-by":"crossref","first-page":"12085","DOI":"10.1523\/JNEUROSCI.3200-08.2008","article-title":"Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand","volume":"28","author":"Wax","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb1065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12035-010-8143-3","article-title":"HspB1 (Hsp 27) expression and neuroprotection in the retina","volume":"42","author":"O\u2019Reilly","year":"2010","journal-title":"Mol. Neurobiol."},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2026.116781_bb1070","doi-asserted-by":"crossref","first-page":"s55","DOI":"10.1185\/030079902125000732","article-title":"Neuroprotection: heat shock proteins","volume":"18","author":"Kelly","year":"2002","journal-title":"Curr. Med. Res. Opin."},{"issue":"11","key":"10.1016\/j.intimp.2026.116781_bb1075","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1172\/JCI58675","article-title":"Accelerating axonal growth promotes motor recovery after peripheral nerve injury in mice","volume":"121","author":"Ma","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.116781_bb1080","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3389\/fimmu.2017.01599","article-title":"The Enigma of Heat Shock Proteins in Immune Tolerance","volume":"8","author":"van Eden","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb1085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2119\/molmed.2014.00058","article-title":"Human myocardium releases heat shock protein 27 (HSP27) after global ischemia: the proinflammatory effect of extracellular HSP27 through toll-like receptor (TLR)-2 and TLR4","volume":"20","author":"Jin","year":"2014","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2026.116781_bb1090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12974-016-0486-x","article-title":"HSP60 plays a regulatory role in IL-1beta-induced microglial inflammation via TLR4-p38 MAPK axis","volume":"13","author":"Swaroop","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116781_bb1095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-015-0003-1","article-title":"Intrathecal heat shock protein 60 mediates neurodegeneration and demyelination in the CNS through a TLR4- and MyD88-dependent pathway","volume":"10","author":"Rosenberger","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb1100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb1105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020513","article-title":"Heat Shock Protein 27 Injection Leads to Caspase Activation in the Visual Pathway and Retinal T-Cell Response","volume":"22","author":"Grotegut","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116781_bb1110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fimmu.2020.00065","article-title":"Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb1115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12974-025-03407-5","article-title":"Target inhibition of SPAK in choroid plexus attenuates T cell infiltration and demyelination in experimental autoimmune encephalomyelitis","volume":"22","author":"Qi","year":"2025","journal-title":"J. Neuroinflammation"},{"issue":"25","key":"10.1016\/j.intimp.2026.116781_bb1120","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1056\/NEJMct071462","article-title":"Natalizumab for multiple sclerosis","volume":"356","author":"Ransohoff","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb1125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1586\/14737175.4.4.571","article-title":"Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS","volume":"4","author":"Rudick","year":"2004","journal-title":"Expert. Rev. Neurother."},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb1130","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/WNL.52.5.1072","article-title":"A safety and pharmacokinetic study of intravenous natalizumab in patients with MS","volume":"52","author":"Sheremata","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb1135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"G. International Natalizumab Multiple Sclerosis Trial, A controlled trial of natalizumab for relapsing multiple sclerosis","volume":"348","author":"Miller","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb1140","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb1145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb1150","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn\u2019s disease","volume":"353","author":"Van Assche","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb1155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMct1101691","article-title":"Fingolimod for multiple sclerosis","volume":"366","author":"Pelletier","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.intimp.2026.116781_bb1160","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb1165","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"L. Kappos, E.W. Radue, P. O'Connor, C. Polman, R. Hohlfeld, P. Calabresi, K. Selmaj, C. Agoropoulou, M. Leyk, L. Zhang-Auberson, P. Burtin, F.S. Group","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb1170","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"J.A. Cohen, F. Barkhof, G. Comi, H.P. Hartung, B.O. Khatri, X. Montalban, J. Pelletier, R. Capra, P. Gallo, G. Izquierdo, K. Tiel-Wilck, A. de Vera, J. Jin, T. Stites, S. Wu, S. Aradhye, L. Kappos, T.S. Group","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"10023","key":"10.1016\/j.intimp.2026.116781_bb1175","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(15)01314-8","article-title":"Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Lublin","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb1180","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1600-6143.2005.00754.x","article-title":"The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I","volume":"5","author":"Koyrakh","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2026.116781_bb1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103417","article-title":"Preventing the antigen-presenting function of retinal microglia blocks autoimmune neuroinflammation by dendritic cell-primed CD4(+) T cells","volume":"153","author":"Shirahama","year":"2025","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb1190","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12974-024-03210-8","article-title":"Suppression of the JAK\/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson's disease","volume":"21","author":"Hong","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb1195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.14283\/jpad.2023.56","article-title":"Neuroprotective Effects of IVIG against Alzheimer' s Disease via Regulation of Antigen Processing and Presentation by MHC Class I Molecules in 3xTg-AD Mice","volume":"10","author":"Fei","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb1200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/jnnp-2015-311486","article-title":"IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia","volume":"88","author":"Kile","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb1205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1474-4422(13)70014-0","article-title":"Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer\u2019s disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial","volume":"12","author":"Dodel","year":"2013","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb1210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/psyg.12055","article-title":"Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer\u2019s disease","volume":"14","author":"Arai","year":"2014","journal-title":"Psychogeriatrics"},{"issue":"18","key":"10.1016\/j.intimp.2026.116781_bb1215","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1212\/WNL.0000000000003904","article-title":"Alzheimer's Disease Cooperative, A phase 3 trial of IV immunoglobulin for Alzheimer disease","volume":"88","author":"Relkin","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2026.116781_bb1220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122997","article-title":"Mesoporous polydopamine nanoparticle-based tolerogenic vaccine induces antigen-specific immune tolerance to prevent and treat autoimmune multiple sclerosis","volume":"316","author":"Phan","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.116781_bb1225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2010.03.012","article-title":"Dexamethasone prevents LPS-induced microglial activation and astroglial impairment in an experimental bacterial meningitis co-culture model","volume":"1329","author":"Hinkerohe","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2026.116781_bb1230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2202-12-49","article-title":"Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia","volume":"12","author":"Huo","year":"2011","journal-title":"BMC Neurosci."},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb1235","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/infdis\/166.4.847","article-title":"Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone","volume":"166","author":"Chao","year":"1992","journal-title":"J. Infect. Dis."},{"issue":"2-3","key":"10.1016\/j.intimp.2026.116781_bb1240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-5728(91)90119-R","article-title":"Effects of dexamethasone on microglial activation in vivo: selective downregulation of major histocompatibility complex class II expression in regenerating facial nucleus","volume":"34","author":"Kiefer","year":"1991","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116781_bb1245","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.neuropharm.2003.11.007","article-title":"Effects of interferon-beta on microglial functions as inflammatory and antigen presenting cells in the central nervous system","volume":"46","author":"Kawanokuchi","year":"2004","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb1250","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.4049\/jimmunol.177.6.3542","article-title":"IFN-beta inhibits T cell activation capacity of central nervous system APCs","volume":"177","author":"Teige","year":"2006","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2026.116781_bb1255","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"CHAMPS Study Group, N Engl J Med"},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb1260","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jnnp-2013-306289","article-title":"Efficacy of subcutaneous interferon beta-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes","volume":"85","author":"De Stefano","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb1265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.msard.2013.07.001","article-title":"Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice","volume":"3","author":"Freedman","year":"2014","journal-title":"Mult Scler Relat Disord"},{"issue":"9268","key":"10.1016\/j.intimp.2026.116781_bb1270","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"G. Early Treatment of Multiple Sclerosis Study, Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb1275","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.intimp.2026.116781_bb1280","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.43.4.662","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS\/MRI Study Group and the IFNB Multiple Sclerosis Study Group","volume":"43","author":"Paty","year":"1993","journal-title":"Neurology"},{"issue":"9316","key":"10.1016\/j.intimp.2026.116781_bb1285","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(02)08430-1","article-title":"Independent Comparison of Interferon Trial Study, Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)","volume":"359","author":"Durelli","year":"2002","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb1290","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.clinthera.2007.09.025","volume":"29","author":"Schwid","year":"2007","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb1295","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jns.2005.08.003","article-title":"the University of British Columbia, Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial","volume":"239","author":"H. Panitch, D. Goodin, G. Francis, P. Chang, P. Coyle, P. O'Connor, D. Li, B. Weinshenker, E.S. Group, M.S.M.R.I.R.G","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.intimp.2026.116781_bb1300","series-title":"PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis)","first-page":"1498","article-title":"Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis","volume":"352(9139)","year":"1998"},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb1305","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.56.12.1628","article-title":"the University of British Columbia, PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS","volume":"56","author":"P.S. Group, M.S.M.R.I.A.G","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb1310","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/1744666X.2018.1426462","article-title":"Interferon beta-1a and beta-1b for patients with multiple sclerosis: updates to current knowledge","volume":"14","author":"Zettl","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"50","key":"10.1016\/j.intimp.2026.116781_bb1315","doi-asserted-by":"crossref","first-page":"32145","DOI":"10.1073\/pnas.2009680117","article-title":"The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease","volume":"117","author":"Lonnemann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109574","article-title":"IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease","volume":"36","author":"Brigas","year":"2021","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.intimp.2026.116781_bb1325","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00415-016-8128-x","article-title":"Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study","volume":"263","author":"Havrdova","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.intimp.2026.116781_bb1330","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2017.02.010","article-title":"Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice","volume":"102","author":"MacPherson","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116781_bb1335","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fimmu.2020.00456","article-title":"A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease","volume":"11","author":"Hampel","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116781_bb1340","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","article-title":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","volume":"47","author":"van Oosten","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb1345","first-page":"457","article-title":"results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group","volume":"53","author":"TNF neutralization in MS","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb1350","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13286","article-title":"Antiallergic drug desloratadine as a selective antagonist of 5HT(2A) receptor ameliorates pathology of Alzheimer's disease model mice by improving microglial dysfunction","volume":"20","author":"Lu","year":"2021","journal-title":"Aging Cell"},{"issue":"9","key":"10.1016\/j.intimp.2026.116781_bb1355","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200785","article-title":"Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model","volume":"217","author":"Wang","year":"2020","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb1360","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11481-016-9720-7","article-title":"Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses","volume":"12","author":"Calvello","year":"2017","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.intimp.2026.116781_bb1365","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-7-30","article-title":"Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation","volume":"7","author":"Wilms","year":"2010","journal-title":"J. Neuroinflammation"},{"issue":"6387","key":"10.1016\/j.intimp.2026.116781_bb1370","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/science.aan4665","article-title":"Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity","volume":"360","author":"Kornberg","year":"2018","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb1375","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.intimp.2026.116781_bb1380","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","volume":"367","author":"Fox","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116781_bb1385","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032011","article-title":"Oral Therapies for Multiple Sclerosis","volume":"9","author":"Faissner","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.116781_bb1390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2015.6549","article-title":"Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease","volume":"25","author":"Lastres-Becker","year":"2016","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.intimp.2026.116781_bb1395","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.14642","article-title":"Minocycline in neurodegenerative and psychiatric diseases: An update","volume":"28","author":"Romero-Miguel","year":"2021","journal-title":"Eur. J. Neurol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926006272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926006272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:00:45Z","timestamp":1789243245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926006272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":279,"alternative-id":["S1567576926006272"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116781","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microglia crosstalk with T cells in neurodegenerative diseases: pathogenesis and treatment targets","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116781"}}